1. Home
  2. LWLG vs SGP Comparison

LWLG vs SGP Comparison

Compare LWLG & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lightwave Logic Inc.

LWLG

Lightwave Logic Inc.

HOLD

Current Price

$5.22

Market Cap

846.4M

Sector

Industrials

ML Signal

HOLD

Logo SpyGlass Pharma Inc. Common Stock

SGP

SpyGlass Pharma Inc. Common Stock

N/A

Current Price

$27.92

Market Cap

968.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LWLG
SGP
Founded
1991
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
846.4M
968.0M
IPO Year
2011
2026

Fundamental Metrics

Financial Performance
Metric
LWLG
SGP
Price
$5.22
$27.92
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$45.00
AVG Volume (30 Days)
2.5M
64.3K
Earning Date
05-08-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
15.79
N/A
EPS
N/A
N/A
Revenue
$236,855.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
147.74
N/A
52 Week Low
$2.84
$17.06
52 Week High
$18.71
$30.56

Technical Indicators

Market Signals
Indicator
LWLG
SGP
Relative Strength Index (RSI) 37.15 57.95
Support Level $3.81 $25.00
Resistance Level $5.65 $27.53
Average True Range (ATR) 0.30 1.29
MACD -0.02 -0.09
Stochastic Oscillator 15.89 42.92

Price Performance

Historical Comparison
LWLG
SGP

About LWLG Lightwave Logic Inc.

Lightwave Logic Inc is a specialty materials and intellectual property company focused on the development and commercialization of proprietary electro-optic (EO) polymer materials designed to enable high-speed optical modulators for data communications and other photonic applications. Its Perkinamine family of EO polymers is designed for integration into silicon photonics (SiPh) and other photonic integrated circuit (PIC) platforms, supporting high-speed optical modulation with lower drive voltage requirements compared with some conventional silicon-based and III-V compound semiconductor approaches. The company operates as a single reportable segment.

About SGP SpyGlass Pharma Inc. Common Stock

SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.

Share on Social Networks: